US Bancorp’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,374
Closed -$4K 4240
2021
Q4
$4K Buy
+1,374
New +$4.98K ﹤0.01% 3748

Other funds holding AUGX

US Bancorp's AUGX Position: Q1 2022 in Review

US Bancorp sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2022, closing a stake of 1,374 shares — an estimated $4K sold.

US Bancorp first reported a position in AUGX in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 22 funds tracked by Wall St. Rank hold AUGX as of Q1 2022.

  • US Bancorp reported no remaining Augmedix, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • US Bancorp sold 1,374 Augmedix, Inc. Common Stock shares in Q1 2022, an estimated $4K.
  • US Bancorp first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • US Bancorp's Augmedix, Inc. Common Stock position peaked at $4K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2022.

Based on US Bancorp's 13F filing for Q1 2022, filed 11 May 2022.